Skip to main content
50°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
97.99
-1.07 (-1.08%)
Streaming Delayed Price
Updated: 10:55 AM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
November 18, 2023
Legend Biotech partnered its DLL3 CAR-T candidates to Novartis in a $1.2 billion agreement, with $100 million offered upfront. Novartis will own worldwide rights to develop, manufacture, and...
Via
Talk Markets
Diversifying Your Portfolio With Plant-Based Options
November 16, 2023
Investors see profit potential in the plant-based market due to rising consumer demand, ESG focus, and the growth of vegan products in various industries, including pharmaceuticals. However, market...
Via
Talk Markets
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector.
Via
The Motley Fool
Verve Loses A Third Of Its Value As Safety Concerns Plague Its Gene-Editing Drug
November 13, 2023
Patients had big decreases in LDL cholesterol. But there were some side effects.
Via
Investor's Business Daily
How Is The Market Feeling About Novartis?
November 10, 2023
Via
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Novartis Hikes Its Earnings Outlook For The Third Time This Year
October 24, 2023
The company also beat third-quarter expectations after spinning off its Sandoz unit.
Via
Investor's Business Daily
Earnings Outlook For Novartis
October 23, 2023
Via
Benzinga
3 Spectacular High-Yield Dividend Stocks to Buy in November
November 05, 2023
Income investors should find plenty to like with these stocks.
Via
The Motley Fool
Novartis' Rare Kidney Disease Candidate Aces Late-Stage Study
October 30, 2023
Novartis AG (NYSE: NVS) released topline results from the interim analysis of the ongoing pivotal Phase 3 ALIGN study of atrasentan in patients with IgA nephropathy (IgAN). IgAN is a major cause of...
Via
Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
The U.S.
Via
Benzinga
Exposures
Product Safety
3 No-Brainer Stocks to Buy for Under $100 Right Now
October 28, 2023
A couple of these stocks might not be available for under $100 for too much longer.
Via
The Motley Fool
2 Green Flags and 1 Red Flag for Novartis Stock
October 27, 2023
The Swiss pharmaceutical company just posted strong Q3 numbers and is going through some big changes.
Via
The Motley Fool
7 Undervalued Stocks to Buy Before Everyone Else
October 26, 2023
Buy these undervalued stocks while they trade at a significant discount compared to their intrinsic valuations.
Via
InvestorPlace
Sanofi Stock Relative Strength Rating Jumps To 84: One To Watch
October 24, 2023
Additionally, Sanofi stock has a decent 83 Composite Rating out of 99, and an 80 Earnings Per Share Rating.
Via
Investor's Business Daily
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
October 24, 2023
NVS earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Avenue Z Hires Leading Digital Media and Technology Executive David Corchado to Lead Team in Global Strategy
October 24, 2023
--News Direct--
Via
News Direct
US Stock Futures Surge Ahead Of Microsoft, Google Earnings: Analyst Says 'Magnificent Seven' Unlikely To See Tesla-Like Volatility After Results
October 24, 2023
Buoyed by earnings optimism, stocks appear on track for a positive open on Tuesday after the tech-heavy Nasdaq Composite Index snapped a four-day losing streak in the previous session. The uptick in...
Via
Benzinga
Topics
Bonds
Stocks
Exposures
Debt Markets
US Equities
Novartis Q3: Earnings Beat, Raised Operating Profit Outlook & More
October 24, 2023
Novartis AG (NYSE: NVS) reported
Via
Benzinga
Topics
Earnings
Exposures
Financial
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
October 23, 2023
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 Healthcare Stocks to invest in for a Healthy Future
October 20, 2023
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners.
Via
InvestorPlace
2 Biotech Stocks That Could Make You Richer
October 17, 2023
These two well-known drugmakers still have some growth fuel in their seemingly empty tanks.
Via
The Motley Fool
3 Unstoppable Stocks to Buy and Hold for Decades
October 17, 2023
These stocks can be pillars for your long-term portfolio, and investing in all three offers excellent diversification.
Via
The Motley Fool
Why Top 1% Biotech MoonLake Just Surged Within Striking Distance Of A Breakout
October 16, 2023
MoonLake says it's skin-disease treatment showed improved promise in a 24-week testing update.
Via
Investor's Business Daily
RayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan
October 10, 2023
JP Morgan has initiated coverage on RayzeBio Inc (NASDAQ: RYZB), representing a pure-play opportunity in the radiopharmaceutical space.
Via
Benzinga
AbbVie Stock Moves Higher With Rising Relative Strength
October 10, 2023
A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Will it continue?
Via
Investor's Business Daily
3 Artificial Intelligence Stocks That Could Outperform the ‘Godfather of AI’
October 09, 2023
These are the AI stocks to buy and hold for multibagger returns in the next 24 months, as they represent quality growth companies.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Protecting Cannabis Products & More: New Sustainable Child-Resistant Packaging By Dymapak
October 05, 2023
Dymapak, a global manufacturer specializing in innovative child-resistant packaging solutions for various industries, has introduced a child-resistant Consumer Packaged Goods (CPG) packaging...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Novartis Shares Decline As Spin Off Sandoz's Market Debut Falls Short of Expected Valuation
October 04, 2023
Sandoz Group AG (OTC: SDZNY) (OTC: SDZXF) enters a new era as a standalone player in generic and biosimilar medicines.
Via
Benzinga
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 04, 2023
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.